AGIO - Agios Pharmaceuticals Inc Stock Price & Dividend Safety Sector: Healthcare | Exchange: NASDAQ Global Select Current Price & Safety Score Price: 38.03 USD StockBonds Safety Grade: D Altman Z-Score (Bankruptcy Risk): 15.10 StockBond Score: 0.00 Company Description Agios Pharmaceuticals Inc is a biopharmaceutical firm dedicated to the research and advancement of new treatments specifically targeting cellular metabolism and related biological fields The companys offerings include PYRUKYND mitapivat a medication designed to activate both wildtype and various mutated pyruvate kinase PK enzymes used in the management of hemolytic anemias Additionally Agios is developing AG946 which is currently undergoing Phase I clinical studies for treating hemolytic anemias and other diseases Established in 2007 the companys main office is located in Cambridge Massachusetts